Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5985 | 1547 | 46.1 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
66 | 3 | LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM | 84415 |
1300 | 2 | THIAZOLIDINEDIONES//PPAR GAMMA//ROSIGLITAZONE | 8578 |
5985 | 1 | 15D PGJ2//15 DEOXY DELTA12 14 PROSTAGLANDIN J2//CYCLOPENTENONE PROSTAGLANDINS | 1547 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 15D PGJ2 | authKW | 633049 | 4% | 53% | 61 |
2 | 15 DEOXY DELTA12 14 PROSTAGLANDIN J2 | authKW | 592935 | 3% | 58% | 52 |
3 | CYCLOPENTENONE PROSTAGLANDINS | authKW | 527752 | 2% | 70% | 38 |
4 | PROSTAGLANDIN J2 | authKW | 232180 | 1% | 59% | 20 |
5 | PPAR GAMMA | authKW | 226300 | 11% | 7% | 167 |
6 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA | authKW | 148411 | 6% | 8% | 90 |
7 | DELTA12 PROSTAGLANDIN J2 | authKW | 140348 | 1% | 89% | 8 |
8 | ROSIGLITAZONE | authKW | 117464 | 5% | 7% | 84 |
9 | 15 DEOXY DELTA12 14 PGJ2 | authKW | 114828 | 1% | 73% | 8 |
10 | PPAR RESEARCH | journal | 74703 | 3% | 9% | 43 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1198 | 26% | 0% | 405 |
2 | Immunology | 1040 | 14% | 0% | 216 |
3 | Pharmacology & Pharmacy | 990 | 17% | 0% | 261 |
4 | Cell Biology | 929 | 14% | 0% | 220 |
5 | Medicine, Research & Experimental | 735 | 9% | 0% | 142 |
6 | Neurosciences | 418 | 12% | 0% | 185 |
7 | Biophysics | 265 | 6% | 0% | 90 |
8 | Endocrinology & Metabolism | 176 | 5% | 0% | 83 |
9 | Critical Care Medicine | 159 | 2% | 0% | 36 |
10 | Respiratory System | 150 | 3% | 0% | 49 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNAL MED CHIKUSA KU | 59210 | 0% | 100% | 3 |
2 | CNR EXPTL MED | 39473 | 0% | 100% | 2 |
3 | EXPT MED NEPHROL | 35512 | 1% | 20% | 9 |
4 | CLIN NEUROL INFLAMMATORY DISORDERS NERVOUS SYST | 26314 | 0% | 67% | 2 |
5 | LUNG BIOL DIS PROGRAM | 25494 | 1% | 9% | 15 |
6 | ESTRUCTURA FUNC PROT | 24278 | 1% | 15% | 8 |
7 | NEUROBIOL DEV SCI | 22655 | 1% | 6% | 19 |
8 | BIOCHEM PATHOBIOCHEM 1 | 22420 | 0% | 23% | 5 |
9 | EXPT MED NEPHROL CRIT CARE | 21039 | 1% | 13% | 8 |
10 | ABT KARDIOVASK MOL BIOL | 19737 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PPAR RESEARCH | 74703 | 3% | 9% | 43 |
2 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 7349 | 2% | 1% | 26 |
3 | EICOSANOIDS | 1450 | 0% | 2% | 3 |
4 | SHOCK | 1420 | 1% | 0% | 17 |
5 | JOURNAL OF IMMUNOLOGY | 1417 | 4% | 0% | 64 |
6 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1398 | 1% | 0% | 15 |
7 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 1091 | 0% | 1% | 7 |
8 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 885 | 0% | 1% | 6 |
9 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 770 | 3% | 0% | 54 |
10 | DRUG NEWS & PERSPECTIVES | 720 | 0% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 15D PGJ2 | 633049 | 4% | 53% | 61 | Search 15D+PGJ2 | Search 15D+PGJ2 |
2 | 15 DEOXY DELTA12 14 PROSTAGLANDIN J2 | 592935 | 3% | 58% | 52 | Search 15+DEOXY+DELTA12+14+PROSTAGLANDIN+J2 | Search 15+DEOXY+DELTA12+14+PROSTAGLANDIN+J2 |
3 | CYCLOPENTENONE PROSTAGLANDINS | 527752 | 2% | 70% | 38 | Search CYCLOPENTENONE+PROSTAGLANDINS | Search CYCLOPENTENONE+PROSTAGLANDINS |
4 | PROSTAGLANDIN J2 | 232180 | 1% | 59% | 20 | Search PROSTAGLANDIN+J2 | Search PROSTAGLANDIN+J2 |
5 | PPAR GAMMA | 226300 | 11% | 7% | 167 | Search PPAR+GAMMA | Search PPAR+GAMMA |
6 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA | 148411 | 6% | 8% | 90 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+GAMMA | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+GAMMA |
7 | DELTA12 PROSTAGLANDIN J2 | 140348 | 1% | 89% | 8 | Search DELTA12+PROSTAGLANDIN+J2 | Search DELTA12+PROSTAGLANDIN+J2 |
8 | ROSIGLITAZONE | 117464 | 5% | 7% | 84 | Search ROSIGLITAZONE | Search ROSIGLITAZONE |
9 | 15 DEOXY DELTA12 14 PGJ2 | 114828 | 1% | 73% | 8 | Search 15+DEOXY+DELTA12+14+PGJ2 | Search 15+DEOXY+DELTA12+14+PGJ2 |
10 | CIGLITAZONE | 60422 | 1% | 22% | 14 | Search CIGLITAZONE | Search CIGLITAZONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SURH, YJ , NA, HK , PARK, JM , LEE, HN , KIM, W , YOON, IS , KIM, DD , (2011) 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2), AN ELECTROPHILIC LIPID MEDIATOR OF ANTI-INFLAMMATORY AND PRO-RESOLVING SIGNALING.BIOCHEMICAL PHARMACOLOGY. VOL. 82. ISSUE 10. P. 1335 -1351 | 81 | 64% | 59 |
2 | PEREZ-SALA, D , GARZON, B , OESTE, CL , DIEZ-DACAL, B , (2011) PROTEOMIC STUDIES ON PROTEIN MODIFICATION BY CYCLOPENTENONE PROSTAGLANDINS: EXPANDING OUR VIEW ON ELECTROPHILE ACTIONS.JOURNAL OF PROTEOMICS. VOL. 74. ISSUE 11. P. 2243 -2263 | 84 | 68% | 17 |
3 | DIEZ-DACAL, B , PEREZ-SALA, D , (2010) ANTI-INFLAMMATORY PROSTANOIDS: FOCUS ON THE INTERACTIONS BETWEEN ELECTROPHILE SIGNALING AND RESOLUTION OF INFLAMMATION.THESCIENTIFICWORLDJOURNAL. VOL. 10. ISSUE . P. 655 -U22 | 87 | 65% | 15 |
4 | STRAUS, DS , GLASS, CK , (2001) CYCLOPENTENONE PROSTAGLANDINS: NEW INSIGHTS ON BIOLOGICAL ACTIVITIES AND CELLULAR TARGETS.MEDICINAL RESEARCH REVIEWS. VOL. 21. ISSUE 3. P. 185 -210 | 78 | 58% | 421 |
5 | SZANTO, A , NAGY, L , (2008) THE MANY FACES OF PPAR GAMMA: ANTI-INFLAMMATORY BY ANY MEANS?.IMMUNOBIOLOGY. VOL. 213. ISSUE 9-10. P. 789 -803 | 76 | 58% | 77 |
6 | OESTE, CL , PEREZ-SALA, D , (2014) MODIFICATION OF CYSTEINE RESIDUES BY CYCLOPENTENONE PROSTAGLANDINS: INTERPLAY WITH REDOX REGULATION OF PROTEIN FUNCTION.MASS SPECTROMETRY REVIEWS. VOL. 33. ISSUE 2. P. 110 -125 | 71 | 55% | 7 |
7 | DREW, PD , XU, JH , RACKE, MK , (2008) PPAR-GAMMA: THERAPEUTIC POTENTIAL FOR MULTIPLE SCLEROSIS.PPAR RESEARCH. VOL. . ISSUE . P. - | 58 | 75% | 11 |
8 | DREW, PD , XU, JH , STORER, PD , CHAVIS, JA , RACKE, MK , (2006) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST REGULATION OF GLIAL ACTIVATION: RELEVANCE TO CNS INFLAMMATORY DISORDERS.NEUROCHEMISTRY INTERNATIONAL. VOL. 49. ISSUE 2. P. 183-189 | 52 | 76% | 56 |
9 | ZINGARELLI, B , COOK, JA , (2005) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA IS A NEW THERAPEUTIC TARGET IN SEPSIS AND INFLAMMATION.SHOCK. VOL. 23. ISSUE 5. P. 393-399 | 59 | 67% | 88 |
10 | SPEARS, M , MCSHARRY, C , THOMSON, NC , (2006) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-7 AGONISTS AS POTENTIAL ANTI-INFLAMMATORY AGENTS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.CLINICAL AND EXPERIMENTAL ALLERGY. VOL. 36. ISSUE 12. P. 1494-1504 | 62 | 64% | 48 |
Classes with closest relation at Level 1 |